AUG 24, 2021 9:23 PM PDT

Myocarditis and COVID-19 Vaccination

WRITTEN BY: Alexandria Bass

Myocarditis has been linked to sudden cardiac death in young, healthy athletes and smallpox, influenza, hepatitis B, and herpes zoster vaccines. As vaccination numbers have increased, myocarditis has become an increasingly apparent side effect of the COVID-19 vaccines not observed in clinical trials for Pfizer and Moderna vaccines that the FDA based its Emergency Use Authorization on in December 2020. Fortunately, the most cases are mild and the incidence rate low, estimated to be 0.016% for women and 0.037% for men.

Data on the association between myocarditis and COVID-19 vaccination come from case studies and a series of mostly younger patients who presented to medical centers for symptoms of myocarditis several days after receiving the COVID-19 vaccine. Symptoms of myocarditis include chest pain, shortness of breath, palpitations, fainting, sweating, and an increase in fatigue. Supporting tests showed cardiac injury through elevated cardiac biomarkers, including serum troponin levels, and abnormal ECG with ST elevation in multiple leads, non-specific ST/T changes, and diffuse T wave inversions. In these case studies, blood work ruled out viral infections, including current COVID-19 infections, and autoimmune diseases that could potentially explain the presence of myocarditis.

One particular report compiled data from multiple case studies to provide more statistics. The average age of patients presenting with myocarditis after COVID-19 vaccination was 28 years old, and 93% were male. The majority of cases occurred after the Pfizer vaccine (60%), followed by Moderna (33%), and then Johnson & Johnson (7%). With Pfizer and Moderna vaccines, myocarditis usually followed the second dose. Clinical symptoms, however, resolved within six days with normal cardiac function preserved.

Treatment of vaccine-related myocarditis is mostly supportive with pain management agents, and symptoms usually resolve spontaneously. For more severe cases, treatment with immune-altering drugs may be beneficial. Severe cases involving cardiogenic shock are exceedingly rare.

To put it in perspective, infection with SARS-CoV-2 has a much higher incidence of cardiac complications than the vaccine. However, these studies provide clinicians and health professionals greater awareness of potential side effects from vaccination that render specific testing and treatment of their own.

Sources: Am Heart J Plus, Am J Cardiol, Can J Cardiol, Cureus

About the Author
  • Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
OCT 05, 2021
Drug Discovery & Development
Drug repurposing for COVID-19
OCT 05, 2021
Drug repurposing for COVID-19
The coronavirus disease that began in 2019 (COVID-19) has infected nearly 235 million individuals and led to t ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
OCT 19, 2021
Immunology
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
OCT 19, 2021
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
In patients with hemophilia A—a hereditary disorder where the blood cannot clot properly—their immune system ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
OCT 21, 2021
Neuroscience
Phone-based Talk Therapy Eases Arthritis-related Insomnia
OCT 21, 2021
Phone-based Talk Therapy Eases Arthritis-related Insomnia
Talk therapy practice known as cognitive behavior therapy (CBT) conducted over the phone helps older adults with arthrit ...
OCT 21, 2021
Cannabis Sciences
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
OCT 21, 2021
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
Fibromyalgia is a common disease impacting millions of adults in the United States. The condition can be extremely debil ...
Loading Comments...